Kidney Cancer — Trials, FDA Actions & Pivotal Research
13 updates aggregated from openFDA and ClinicalTrials.gov, covering trial milestones, FDA actions, and pivotal publications about Kidney Cancer.
Synced daily from openFDA and ClinicalTrials.gov. Last sync: .
Drugs with Kidney Cancer trials
Recruiting trials by city
Cities where Kidney Cancer trials in our archive had recruiting sites. Each link lists every currently recruiting paid clinical trial at that location.
Updates
2026
- Results postedPembrolizumab/Lenvatinib Combo Shows Objective Response in Renal Cell Carcinoma· Apr 20, 2026· drug: Pembrolizumab
- Results postedKeytruda SC Formulation Preferred by Cancer Patients in Preference Study· Apr 8, 2026· drug: Pembrolizumab
- Results postedPembrolizumab Combination Trial for Solid Tumors Reports DLTs at High Dose· Mar 27, 2026· drug: Pembrolizumab
- Results postedPembrolizumab Combination Shows Responses in Refractory Advanced Cancers· Jan 29, 2026· drug: Pembrolizumab
- Results postedKeytruda/TAK-500 Solid Tumor Study Terminated, Adverse Event Data Posted· Jan 22, 2026· drug: Pembrolizumab
- Primary completionNivolumab Phase 3 Trial in Renal Cell Carcinoma Completes Primary Study· Jan 20, 2026· drug: Nivolumab
2025
- Results postedRenal Cell Carcinoma: Terminated Perfusion MRI Study Posts Repeatability Data· Dec 19, 2025
- Results postedPembrolizumab + Lenvatinib Shows 50.6% ORR in 1L Advanced nccRCC· Dec 3, 2025· drug: Pembrolizumab
- Results postedKidney Cancer: Histotripsy System Achieves 100% Technical Success· Dec 2, 2025
- Results postedMedtronic Hugo RAS System: Urologic Surgery Trial Results Posted· Nov 25, 2025
- Results postedNivolumab Combination Shows Better PFS, ORR in tRCC Trial· Oct 10, 2025· drug: Nivolumab
- Results postedNivolumab Combination Trial Shows Improved PFS in Advanced Renal Cell Carcinoma· Sep 10, 2025· drug: Nivolumab
- Results postedCancer Patients' Treatment Priorities Posted for Elderly and Young· Jul 1, 2025